Boston Scientific Earnings & Forecasts

Boston Scientific (BSX) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

분기별 실적 서프라이즈 금액

회계 분기	보고된 날짜	실제 EPS	예상 EPS	놀라다 %
Q2	Jul 29, 2026	$0.86	$0.83	3.61 %
Q1	Apr 22, 2026	$0.80	$0.79	1.27 %
Q4	Feb 4, 2026	$0.80	$0.78	2.56 %
Q3	Oct 22, 2025	$0.75	$0.71	5.63 %

Quarterly Revenue (Billions)

분기별 수익 깜짝 금액

회계 분기	보고된 날짜	실제 수익	예상 수익	놀라다 %
Q2	Jul 29, 2026	$5.44B	$5.38B	1.22 %
Q1	Apr 22, 2026	$5.20B	$5.18B	0.45 %
Q4	Feb 4, 2026	$5.29B	$5.28B	0.18 %
Q3	Oct 22, 2025	$5.07B	$4.97B	1.86 %

Boston Scientific Guidance

Boston Scientific (BSX)은 지난 7월 29, 2026에 Q3 2026의 실적 전망을 발표했습니다. 회사는 주당순이익을 $0.8 - $0.82 범위로 전망했으며, 이는 시장 컨센서스 EPS 추정치인 $0.84보다 높은 수치입니다. Boston Scientific는 또한 해당 기간의 매출을 $5.22B - $5.32B 범위로 전망했습니다.

이전 가이던스와 비교하여 Boston Scientific는 매출 전망치를 이전 범위인 하향 조정됨에서 $21.18B - $21.38B로 상향 조정했습니다.

Boston Scientific은 35과 10월 26, 2022 사이에 7월 29, 2026개의 지침 업데이트를 발표했습니다. During this period, the company raised its outlook 13 times and lowered it 18 times, providing investors with insight into management's evolving expectations.

Recent Earnings Results

Metric	Q2 '26	Q1 '26	Q4 '25	Q3 '25
Earnings Per Share (Non-GAAP)
Estimate	$0.83	$0.79	$0.78	$0.71
Actual	$0.86	$0.80	$0.80	$0.75
Surprise	+3.61%	+1.27%	+2.56%	+5.63%
Revenue
Estimate	$5.38B	$5.18B	$5.28B	$4.97B
Actual	$5.44B	$5.20B	$5.29B	$5.07B
Surprise	+1.22%	+0.45%	+0.18%	+1.86%

Analyst Estimates — Forward PeriodsSource: Wall Street consensus

Metric	Q3 '26E	Q4 '26E	Q1 '27E	Q2 '27E
Earnings Per Share (Non-GAAP)
Consensus	$0.79	$0.84	$0.82	$0.87
Revenue
Consensus	$5.22B	$5.43B	—	—

More with Benzinga EdgeGet Access

PRO
Boston Scientific Lowers FY2026 Adj EPS Guidance from $3.34-$3.41 to $3.28-$3.32 vs $3.36 Est; Lowers FY2026 Sales Guidance from $21.479B-$21.780B to $21.178B-$21.379B vs $21.562B Est

Boston Scientific (NYSE:BSX) lowers FY2026 Adj EPS guidance from $3.34-$3.41 to $3.28-$3.32 vs $3.36 analyst estimate. Lowers FY2026 sales outlook from $21.479 billion-$21.780 billion to $21.178 billion-$21.379 billion

Benzinga Newsdesk

PRO
Boston Scientific Q2 Adj. EPS $0.86 Beats $0.83 Estimate, Sales $5.442B Beat $5.361B Estimate

Boston Scientific (NYSE:BSX) reported quarterly earnings of $0.86 per share which beat the analyst consensus estimate of $0.83 by 3.61 percent. This is a 14.67 percent increase over earnings of $0.75 per share from the

Benzinga Newsdesk

Dow Jones Hit Records Above 50,600 As Oil Sinks Below $90: Stock Market Today

Dow notches fresh all-time high while Nasdaq 100 drops 0.7% as chip stocks unwind. Oil sinks nearly 4% after Iran-US peace draft headlines clash with White House denial.

Piero Cingari

Boston Scientific Corp